Published in J Am Soc Nephrol on December 01, 1994
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2012) 2.78
Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol (2011) 1.65
Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2011) 1.62
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int (2015) 1.50
Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol (2009) 1.36
Early renal abnormalities in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.32
Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol (2014) 1.24
Nephrotic syndrome and IgA nephropathy in polycystic kidney disease. Clin Exp Nephrol (2006) 1.19
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease. Kidney Int (2015) 1.17
Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.16
Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int (2011) 1.13
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Clin J Am Soc Nephrol (2010) 1.12
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One (2013) 1.12
The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease. Clin Exp Nephrol (2011) 1.12
Developments in the management of autosomal dominant polycystic kidney disease. Ther Clin Risk Manag (2008) 1.06
Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2014) 1.05
Hypertension in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis (2010) 1.04
Polycystic kidney disease: pathogenesis and potential therapies. Biochim Biophys Acta (2010) 1.02
Environmental tobacco smoke furthers progression of diabetic nephropathy. Am J Med Sci (2011) 0.96
Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease. Pediatr Nephrol (2010) 0.95
Association between smoking and chronic kidney disease: a case control study. BMC Public Health (2010) 0.95
Autosomal dominant polycystic kidney disease with diffuse proliferative glomerulonephritis - an unusual association: a case report and review of the literature. J Med Case Rep (2010) 0.93
Molecular pathways and therapies in autosomal-dominant polycystic kidney disease. Physiology (Bethesda) (2015) 0.93
Cigarette smoking: an important renal risk factor - far beyond carcinogenesis. Tob Induc Dis (2002) 0.89
Urinary biomarkers at early ADPKD disease stage. PLoS One (2015) 0.87
Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease. Clin Exp Nephrol (2006) 0.85
Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. Clin Exp Nephrol (2012) 0.85
An update on 'progression promoters' in renal diseases. J Natl Med Assoc (2003) 0.84
Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants. Contemp Clin Trials (2011) 0.83
A rare cause of nephrotic syndrome in autosomal-dominant polycystic kidney disease. NDT Plus (2008) 0.82
Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease. Physiol Rep (2014) 0.81
ADPKD: Prototype of Cardiorenal Syndrome Type 4. Int J Nephrol (2010) 0.81
Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease. PLoS One (2014) 0.80
Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD. Pediatr Nephrol (2008) 0.80
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD). Clin Kidney J (2013) 0.80
Geographic differences in the increasing ESRD rate have disappeared in Japan. Clin Exp Nephrol (2011) 0.79
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4. Clin J Am Soc Nephrol (2016) 0.78
Nicotine signaling and progression of chronic kidney disease in smokers. Biochem Pharmacol (2013) 0.78
Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats. PLoS One (2015) 0.78
The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol (2016) 0.76
Autosomal dominant polycystic kidney disease in children. Curr Opin Pediatr (2015) 0.76
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients. Medicine (Baltimore) (2016) 0.75
Urinary biomarkers for monitoring disease progression in the Han:SPRD-cy rat model of autosomal-dominant polycystic kidney disease. Comp Med (2010) 0.75
Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney disease. Kidney Res Clin Pract (2012) 0.75
Nephrotic syndrome and autosomal dominant polycystic kidney disease. Clin Kidney J (2012) 0.75
The Urine Preservative Acetic Acid Degrades Urine Protein: Implications for Urine Biorepositories and the AASK Cohort Study. J Am Soc Nephrol (2017) 0.75
Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease. BMC Nephrol (2013) 0.75
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol (2017) 0.75
Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet (2001) 9.75
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Sexual behaviour in Britain: early heterosexual experience. Lancet (2001) 7.62
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med (1998) 7.18
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56
Measuring sexual behaviour: methodological challenges in survey research. Sex Transm Infect (2001) 6.21
The spectrum of rhabdomyolysis. Medicine (Baltimore) (1982) 6.15
Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science (1988) 5.91
Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ (1997) 5.29
Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ (2000) 4.51
Human C'3: evidence for the liver as the primary site of synthesis. Science (1969) 4.17
From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ (1998) 4.09
Pupil-led sex education in England (RIPPLE study): cluster-randomised intervention trial. Lancet (2004) 3.86
Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ (1994) 3.71
Controlling genital chlamydial infection. BMJ (1996) 3.29
The human costs of tobacco use (1) N Engl J Med (1994) 3.24
Sexual lifestyles under scrutiny. Nature (1990) 3.19
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest (2001) 2.84
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82
Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med (1985) 2.82
Risk behaviours for HIV infection among injecting drug users attending a drug dependency clinic. BMJ (1989) 2.68
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district. Br Med J (Clin Res Ed) (1986) 2.54
Active surveillance of sexual behaviour among homosexual men in London. Commun Dis Public Health (1998) 2.45
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care (2000) 2.36
Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med (1992) 2.34
A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ (2001) 2.30
Provision of sex education and early sexual experience: the relation examined. BMJ (1995) 2.21
Attitudes to tracing and notifying contacts of people with HIV infection. BMJ (1992) 2.19
Osmotic and nonosmotic control of vasopressin release. Am J Physiol (1979) 2.18
A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV), the causative agent of AIDS. IMA J Math Appl Med Biol (1986) 2.18
Preliminary report: accurate assays for anti-HIV in urine. Lancet (1990) 2.17
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med (1988) 2.16
Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med (1978) 2.13
AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13
Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int (2001) 2.09
Maintaining patient access to GUM clinics: is it compatible with appointments? Sex Transm Infect (2003) 2.08
Increasing risk behaviour and high levels of undiagnosed HIV infection in a community sample of homosexual men. Sex Transm Infect (2004) 2.06
Surveillance of sexual behaviour among homosexual men in a central London health authority. Genitourin Med (1997) 2.03
We're at war--but where are our troops? Hosp Pract (Off Ed) (1994) 2.01
Methodology of the National Survey of Sexual Attitudes and Lifestyles. J R Stat Soc Ser A Stat Soc (1993) 1.95
Who reports sexual function problems? Empirical evidence from Britain's 2000 National Survey of Sexual Attitudes and Lifestyles. Sex Transm Infect (2005) 1.95
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Br J Pharmacol (1976) 1.95
The human costs of tobacco use (2) N Engl J Med (1994) 1.93
Transformation of chloroplast ribosomal RNA genes in Chlamydomonas: molecular and genetic characterization of integration events. Genetics (1990) 1.93
Immunofixation electrophoresis: a technique for the study of protein polymorphism. Vox Sang (1969) 1.88
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.86
Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest (1975) 1.85
Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.81
Behavioural intervention trials for HIV/STD prevention in schools: are they feasible? Sex Transm Infect (1998) 1.78
Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics (1993) 1.77
Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med (1987) 1.76
Intraoperative left ventricular perforation with false aneurysm formation. Br Heart J (1976) 1.75
Trends in HIV testing and recording of HIV status in the UK primary care setting: a retrospective cohort study 1995-2005. Sex Transm Infect (2009) 1.74
Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis (1999) 1.74
Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. J Clin Invest (1972) 1.72
An evaluation of partner notification for HIV infection in genitourinary medicine clinics in England. AIDS (1998) 1.71
Voluntary universal antenatal HIV testing. Br J Obstet Gynaecol (1996) 1.71
The role and effectiveness of partner notification in STD control: a review. Genitourin Med (1996) 1.68
Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest (1970) 1.67
The accuracy of reported sensitive sexual behaviour in Britain: exploring the extent of change 1990-2000. Sex Transm Infect (2002) 1.67
Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978. Hum Genet (1980) 1.66
Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses. Sex Transm Infect (2008) 1.66
A school-based randomized controlled trial of peer-led sex education in England. Control Clin Trials (2003) 1.65
Road safety in drivers with Parkinson disease. Neurology (2009) 1.65
Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1998) 1.64
Nonoliguric acute renal failure. N Engl J Med (1977) 1.64
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int (1998) 1.64
Unrecognized adult salicylate intoxication. Ann Intern Med (1976) 1.63
Syndromes of toluene sniffing in adults. Ann Intern Med (1981) 1.63
Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet (1995) 1.62
Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care (2007) 1.59
Long-term follow-up of upper extremity implanted venous access devices in oncology patients. J Vasc Interv Radiol (1999) 1.56
Increased frequency of heterozygotes for alpha1 antitrypsin variants in individuals with either sex chromosome mosaicism or trisomy 21. Nature (1976) 1.56
Mechanism of antidiuretic effect of beta adrenergic stimulation. J Clin Invest (1972) 1.54
Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol (1997) 1.52
Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.50
Postoperative hyponatremia. A prospective study. Arch Intern Med (1986) 1.50
Role of vasopressin in the impaired water excretion of glucocorticoid deficiency. Kidney Int (1980) 1.50
Assessing participation bias in a sexual behaviour survey: implications for measuring HIV risk. AIDS (1997) 1.49
Private sexual behavior, public opinion, and public health policy related to sexually transmitted diseases: a US-British comparison. Am J Public Health (1998) 1.49
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med (1981) 1.49
Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med (1982) 1.48
Disease progression and survival in HIV-1-infected Africans in London. AIDS (1998) 1.47
Gastrotracheal fistula: a late complication after transhiatal esophagectomy. Ann Thorac Surg (1989) 1.46
Cytokines, nitric oxide, heat shock proteins and virulence in Toxoplasma. Parasitol Today (1999) 1.45
Treating sexually transmitted infections in primary care: a missed opportunity? Sex Transm Infect (2003) 1.45